Alpha Release — LOOM is in early access. Try the free tier for small projects.

BOSTON & NEW ENGLAND TECH

Research Speed vs. Regulatory Reality: The Boston Code Dilemma

Your ML model needs to iterate daily. Your FDA submission needs complete traceability. Same codebase. Conflicting requirements. Sound familiar?

The Kendall Square Paradox

Boston's biotech corridor runs on speed. Research timelines are measured in grant cycles. Every quarter without results is another quarter the lab burns runway.

But the moment research becomes product, everything changes. FDA wants traceability. HIPAA wants audit trails. Your "move fast" codebase suddenly needs to prove it moved correctly.

Most teams try to retrofit compliance. LOOM lets you see what's actually there—so you know what needs to change before the auditors do.

What We See in Boston Life Sciences Codebases

The Research-to-Product Gap

The Python notebook that proved the concept became the Python script that became the "production system." Nobody planned for scale, validation, or maintenance. It just happened.

Common in: ML/AI startups emerging from labs

The PhD Code Problem

Brilliant algorithms written by researchers who never learned software engineering. The code works. Nobody can modify it. The original author is now a professor at Stanford.

Risk: Mission-critical code with zero maintainability

The Compliance Retrofit

Series B funding requires FDA pathway. Suddenly that research codebase needs version control, audit logs, and traceability. But nobody knows what it actually does at a detailed level.

Timeline: 6 months to submission, 6 years of code to untangle

The Data Pipeline Labyrinth

Patient data flows through 14 transformations across 8 services. HIPAA requires you to know where PHI goes. Your data engineers know their piece. Nobody sees the whole path.

Audit question: "Where does patient data flow?" should not take 2 weeks

Boston Biotech Code Analysis

The Research-to-Production Transition

73%
of biotech codebases started as research projects
8x
higher complexity in codebases with regulatory requirements
56%
of PHI touchpoints are undocumented

Based on LOOM analysis of codebases from Boston-area life sciences companies, 2024-2025.

Greater Boston Tech Ecosystem

Kendall Square / Cambridge

Biotech epicenter. Where research becomes product. Codebases transitioning from lab notebooks to FDA submissions.

Seaport District

Healthtech and digital health startups. Patient-facing applications with HIPAA requirements and startup timelines.

Route 128 Corridor

Enterprise health IT. Legacy systems that hospitals depend on. Code that absolutely cannot fail.

Is LOOM Right for Your Boston Team?

Probably Not If...

  • You're still in pure research mode with no product timeline
  • Your codebase is under 5,000 lines with full test coverage
  • You have dedicated documentation that's actually current

Essential If...

  • FDA or HIPAA compliance is on your near-term roadmap
  • Your research code is becoming your production code
  • You need to answer "where does this data flow?" in hours, not weeks

See Your Data Flows Before Auditors Ask

Start with our free Browser Security Scanner to experience LOOM's approach to visibility. Then join the waitlist for early access.

Try Free Scanner Join Waitlist